20/20 OptimEyes Technologies Patents

Patent portfolio assigned to 20/20 OptimEyes Technologies (verified via public assignee records). Early-stage McMaster University (Hamilton, Ontario) biotech spin-out; patented micelle drug-delivery tech for extended-dosing eye drops (glaucoma/dry eye). 'Patented' technology referenced in profile sources; no specific patent number/count verified and no named customers found (pre-commercial).